Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic Role of Nodal Status and Clinically Asymptomatic Valvular Insufficiency in Patients with HER2-positive Breast Cancer Treated with Chemotherapy, Radiotherapy and Trastuzumab in an Adjuvant Setting.
Grela-Wojewoda A, Niemiec J, Sas-Korczyńska B, Cedrych I, Domagała-Haduch M, Adamczyk A, Ambicka A, Kołacz J, Jakubowicz J. Grela-Wojewoda A, et al. Among authors: cedrych i. Anticancer Res. 2015 Jul;35(7):4063-72. Anticancer Res. 2015. PMID: 26124356
Prognostic role of lymphatic vessel density and lymphovascular invasion in chemotherapy-naive and chemotherapy-treated patients with invasive breast cancer.
Niemiec JA, Adamczyk A, Ambicka A, Mucha-Małecka A, Wysocki WM, Biesaga B, Ziobro M, Cedrych I, Grela-Wojewoda A, Domagała-Haduch M, Wysocka J, Ryś J, Sas-Korczyńska B. Niemiec JA, et al. Among authors: cedrych i. Am J Transl Res. 2017 Mar 15;9(3):1435-1447. eCollection 2017. Am J Transl Res. 2017. PMID: 28386369 Free PMC article.
Prognostic value of PIK3CA mutation status, PTEN and androgen receptor expression for metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting.
Adamczyk A, Niemiec J, Janecka A, Harazin-Lechowska A, Ambicka A, Grela-Wojewoda A, Domagała-Haduch M, Cedrych I, Majchrzyk K, Kruczak A, Ryś J, Jakubowicz J. Adamczyk A, et al. Among authors: cedrych i. Pol J Pathol. 2015 Jun;66(2):133-41. doi: 10.5114/pjp.2015.53009. Pol J Pathol. 2015. PMID: 26247526 Free article.
Proteins Involved in HER2 Signalling Pathway, Their Relations and Influence on Metastasis-Free Survival in HER2-Positive Breast Cancer Patients Treated with Trastuzumab in Adjuvant Setting.
Adamczyk A, Grela-Wojewoda A, Domagała-Haduch M, Ambicka A, Harazin-Lechowska A, Janecka A, Cedrych I, Majchrzyk K, Kruczak A, Ryś J, Niemiec J. Adamczyk A, et al. Among authors: cedrych i. J Cancer. 2017 Jan 1;8(1):131-139. doi: 10.7150/jca.16239. eCollection 2017. J Cancer. 2017. PMID: 28123607 Free PMC article.
Inhibitory PARP w terapii raka jajnika.
Kruczała MA, Grela-Wojewoda A, Cedrych I. Kruczała MA, et al. Among authors: cedrych i. Ginekol Pol. 2016;87(2):131-4. doi: 10.17772/gp/59268. Ginekol Pol. 2016. PMID: 27306290 Free article. Review. English, Polish.
Systemic treatment of non-small cell lung cancer brain metastases.
Cedrych I, Kruczała MA, Walasek T, Jakubowicz J, Blecharz P, Reinfuss M. Cedrych I, et al. Contemp Oncol (Pozn). 2016;20(5):352-357. doi: 10.5114/wo.2016.64593. Epub 2016 Dec 20. Contemp Oncol (Pozn). 2016. PMID: 28373815 Free PMC article. Review.
Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland.
Wojcik P, Jasiowka M, Strycharz E, Sobol M, Hodorowicz-Zaniewska D, Skotnicki P, Byrski T, Blecharz P, Marczyk E, Cedrych I, Jakubowicz J, Lubiński J, Sopik V, Narod S, Pierzchalski P. Wojcik P, et al. Among authors: cedrych i. Hered Cancer Clin Pract. 2016 Feb 3;14:5. doi: 10.1186/s13053-016-0046-5. eCollection 2016. Hered Cancer Clin Pract. 2016. PMID: 26843898 Free PMC article.
16 results